Citius Oncology (CTOR) Treasury Shares (2022 - 2024)
Citius Oncology (CTOR) posted quarterly Treasury Shares of $4.3 million for Q2 2024, down 34.67% year-over-year from $6.6 million in Q3 2023, and little changed quarter-over-quarter from $4.3 million in Q1 2024.
Citius Oncology (CTOR) Treasury Shares (2022 - 2024) Analysis & Trends
Citius Oncology (CTOR) has reported Treasury Shares for 3 consecutive years, with $4.3 million the latest figure, recorded in Q2 2024.
- In Q2 2024, Treasury Shares fell 34.67% year-over-year to $4.3 million; the TTM figure through Jun 2024 stood at $4.3 million (down 34.67% YoY), while the FY2023 annual figure was $6.6 million, changed 0.0% from the prior year.
- Treasury Shares steadied at $4.3 million in Q2 2024 per CTOR's latest filing, from $4.3 million in the prior quarter.
- Across five years, Treasury Shares topped out at $6.6 million in Q4 2022 and bottomed at $2.3 million in Q4 2023.
- Historically, Treasury Shares has averaged $5.3 million across 3 years, with a median of $6.6 million in 2022.
- Annual changes were most pronounced in 2023 — Treasury Shares sank 64.53% — and 2024, when it plunged 34.67%.
- Citius Oncology's Treasury Shares stood at $6.6 million in 2022, then tumbled by 64.53% to $2.3 million in 2023, then jumped by 84.2% to $4.3 million in 2024.
- Business Quant data shows CTOR's Treasury Shares at $4.3 million in Q2 2024, $4.3 million in Q1 2024, and $2.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 19.00 Mn |
| 10 | Citius Oncology | 80.25 Mn | 80.25 Mn | 1.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4.31 Mn |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 2.34 Mn |
| Dec 31, 2023 | 2.34 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 6.60 Mn |
| Mar 31, 2023 | 6.60 Mn |
| Dec 31, 2022 | 6.60 Mn |
| Dec 31, 2022 | 6.60 Mn |